Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
August 25, 2009
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease
Christopher J Helal, Zhijun Kang, John C Lucas, et al.
ACS Chemical Neuroscience
|
June 14, 2017
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors
Travis T Wager, Paul Galatsis, Ramalakshmi Y Chandrasekaran, et al.
ACS Chemical Neuroscience
|
October 10, 2014
Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior
Travis T Wager, Ramalakshmi Y Chandrasekaran, Jenifer Bradley, et al.
Cell Chemical Biology
|
September 11, 2018
Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State
Martin Kurnik, Cagla Sahin, Camilla Bertel Andersen, et al.
Journal of Medicinal Chemistry
|
August 8, 2013
Ligand-protein interactions of selective casein kinase 1δ inhibitors
Scot Mente, Eric Arnold, Todd Butler, et al.
Journal of Medicinal Chemistry
|
November 18, 2017
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase
Christopher R Butler, Elizabeth M Beck, Anthony Harris, et al.
Journal of Medicinal Chemistry
|
June 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine Receptor
Christopher R Butler, Michael Popiolek, Laura A McAllister, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2010
A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists
John A Lowe, Shari L DeNinno, Jotham W Coe, et al.
Journal of Medicinal Chemistry
|
May 15, 2009
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors
Allen J Duplantier, Stacey L Becker, Michael J Bohanon, et al.
Cancer Discovery
|
December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
Alexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Bioorganic & Medicinal Chemistry Letters
|
August 25, 2009
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease
Christopher J Helal, Zhijun Kang, John C Lucas, et al.
ACS Chemical Neuroscience
|
June 14, 2017
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors
Travis T Wager, Paul Galatsis, Ramalakshmi Y Chandrasekaran, et al.
ACS Chemical Neuroscience
|
October 10, 2014
Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior
Travis T Wager, Ramalakshmi Y Chandrasekaran, Jenifer Bradley, et al.
Cell Chemical Biology
|
September 11, 2018
Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State
Martin Kurnik, Cagla Sahin, Camilla Bertel Andersen, et al.
Journal of Medicinal Chemistry
|
August 8, 2013
Ligand-protein interactions of selective casein kinase 1δ inhibitors
Scot Mente, Eric Arnold, Todd Butler, et al.
Journal of Medicinal Chemistry
|
November 18, 2017
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase
Christopher R Butler, Elizabeth M Beck, Anthony Harris, et al.
Journal of Medicinal Chemistry
|
June 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine Receptor
Christopher R Butler, Michael Popiolek, Laura A McAllister, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 29, 2010
A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6/4beta4 nicotinic receptor agonists
John A Lowe, Shari L DeNinno, Jotham W Coe, et al.
Journal of Medicinal Chemistry
|
May 15, 2009
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors
Allen J Duplantier, Stacey L Becker, Michael J Bohanon, et al.
Cancer Discovery
|
December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
Alexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Page
of 3